NCT05355779

Brief Summary

This study aims to fill the gaps in knowledge regarding the effects of cancer and its treatment on Hong Kong Chinese paediatric cancer survivors, especially during the transition period, to further capture a deeper understanding of the challenges, views and needs of Hong Kong Chinese paediatric cancer survivors and the key stakeholders around them via face-to-face conversations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 24, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 2, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

August 1, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

February 28, 2024

Status Verified

August 1, 2022

Enrollment Period

1.2 years

First QC Date

January 24, 2022

Last Update Submit

February 27, 2024

Conditions

Keywords

Paediatric CancerSurvivorshipPost-treatmentTransition periodQualitative studyRehabilitationNeedsPreferences

Outcome Measures

Primary Outcomes (2)

  • An individual, a face-to-face interview will be conducted with the participants to identify the needs of paediatric cancer survivors during the transition period after cancer treatment

    Semi-structured and open-ended questions will be used to collect qualitative data from the participants

    through study completion, an average of 15 months

  • An individual, a face-to-face interview will be conducted with the participants to assess the key elements in the development of a paediatric survivorship programme

    Semi-structured and open-ended questions will be used to collect qualitative data from the participants

    through study completion, an average of 15 months

Study Arms (1)

Interviewees

Paediatric cancer survivors, their parent/caregiver and health care professionals will be invited to express their views and perspectives in an interview with the researcher

Other: Not Application as this is a qualitative study

Interventions

Not Application as this is a qualitative study

Interviewees

Eligibility Criteria

Age9 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Paediatric cancer survivors

You may qualify if:

  • able to speak Cantonese and read Chinese
  • aged between 9 and 18 years of age
  • Should have completed cancer treatment between 2 months and 2 years earlier

You may not qualify if:

  • Children who received a diagnosis and completed treatment before the age of 9 will be excluded as they might have vague memories of the course of cancer and may have limited verbal and cognitive ability to express themselves
  • Children of exclude parents will be exclueded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hong Kong Children's Hospital

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Joyce Chung

    The Hong Kong Polytechnic University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2022

First Posted

May 2, 2022

Study Start

August 1, 2022

Primary Completion

September 30, 2023

Study Completion

December 1, 2023

Last Updated

February 28, 2024

Record last verified: 2022-08

Locations